Back to search

Randomized Trial of Folic Acid for Prevention of Cardiovascular Events in End-Stage Renal Disease

Data up to Jan 2025

Published2004
Citations251
References24

Total Citations Per Year

Abstract

References (24)

Nonparametric Statistical Methods

1999 • 6,387 citations

Clinical epidemiology of cardiovascular disease in chronic renal disease

1998 • 3,896 citations

Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular Disease

1998 • 672 citations

Prospective Study of Coronary Heart Disease Incidence in Relation to Fasting Total Homocysteine, Related Genetic Polymorphisms, and B Vitamins

1998 • 616 citations

Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study

1994 • 540 citations

Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels

2001 • 538 citations

Prospective Study of Hyperhomocysteinemia as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease

1998 • 412 citations

Folic Acid Improves Endothelial Function in Coronary Artery Disease via Mechanisms Largely Independent of Homocysteine Lowering

2002 • 311 citations

Elevated Fasting Total Plasma Homocysteine Levels and Cardiovascular Disease Outcomes in Maintenance Dialysis Patients

1997 • 299 citations

Malnutrition, cardiac disease, and mortality: An integrated point of view

1998 • 297 citations

Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

2002 • 286 citations

High dose B-vitamin treatment of hyperhomocysteinemia in dialysis patients

1996 • 242 citations

Hyperhomocysteinemia in Chronic Renal Disease

1999 • 241 citations

Folate Improves Endothelial Function in Coronary Artery Disease

2001 • 241 citations

Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients

2000 • 211 citations

Epidemiology of cardiovascular risk factors in chronic renal disease.

1998 • 160 citations

Long-Term Homocysteine-Lowering Treatment With Folic Acid Plus Pyridoxine Is Associated With Decreased Blood Pressure but Not With Improved Brachial Artery Endothelium-Dependent Vasodilation or Carotid Artery Stiffness

2001 • 150 citations

Plasma Total Homocysteine and Risk of Angina Pectoris With Subsequent Coronary Artery Bypass Surgery

1997 • 103 citations

An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease

2001 • 93 citations

Major determinants of hyperhomocysteinemia in peritoneal dialysis patients

1998 • 81 citations

The impact of an amino acids-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass

1999 • 50 citations

The C677T Methylenetetrahydrofolate Reductase Gene Mutation in Hemodialysis Patients

2000 • 46 citations

Treatment of hyperhomocysteinemia in hemodialysis patients and renal transplant recipients

2001 • 39 citations

TREATMENT OF MILD HYPERHOMOCYSTEINEMIA IN RENAL TRANSPLANT RECIPIENTS VERSUS HEMODIALYSIS PATIENTS1

2000 • 30 citations

Cited By (0)

Loading...
Randomized Trial of Folic Acid for Prevention of Cardiovascular Events in End-Stage Renal… (2004) – Journal of the American Society of Nephrology | Metascience Observatory Explorer